127 related articles for article (PubMed ID: 21557726)
1. Down-regulation of c-Myc expression inhibits the invasion of bile duct carcinoma cells.
Li ZR; Wu YF; Ma CY; Nie SD; Mao XH; Shi YZ
Cell Biol Int; 2011 Aug; 35(8):799-802. PubMed ID: 21557726
[TBL] [Abstract][Full Text] [Related]
2. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
Shi Z; Chen ML; He QL; Zeng JH
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
[TBL] [Abstract][Full Text] [Related]
3. [Effect of Bcl-2 antisense phosphorothioate oligodeoxynucleotides on bile duct carcinoma cell line QBC939].
Peng C; Tang HH; Huang P; Chen MX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):536-9. PubMed ID: 16320583
[TBL] [Abstract][Full Text] [Related]
4. Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells.
Nagai K; Ishii H; Miyoshi N; Hoshino H; Saito T; Sato T; Tomimaru Y; Kobayashi S; Nagano H; Sekimoto M; Doki Y; Mori M
Biochem Biophys Res Commun; 2010 Apr; 395(2):258-63. PubMed ID: 20381452
[TBL] [Abstract][Full Text] [Related]
5. [Effect of small interfering RNA targeting p63 on the proliferation and invasiveness of human cholangiocarcinoma cells in vitro].
Liu Z; Zhang M; Li Y; Zhang Y; She Z
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):207-10. PubMed ID: 22381759
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
7. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
[TBL] [Abstract][Full Text] [Related]
8. [Molecular mechanism of γ-aminobutyric acid inhibitory on the growth of cholangiocarcinoma QBC939 cell line].
Zhu CL; Huang Q; Liu CH; Xie F; Zhu K
Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):261-5. PubMed ID: 23859331
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
10. Mucins 1-shRNA inhibit the proliferation and HIF-1alpha protein expression on human cholangiocarcinoma cells.
Li ZR; Wei JL; Li ZZ; Li SF
Cell Biol Int; 2013 Feb; 37(2):121-5. PubMed ID: 23339102
[TBL] [Abstract][Full Text] [Related]
11. [Effect of down regulation of laminin receptor on urokinase-type plasminogen activator expression in human bile duct carcinoma cells].
Wang SG; Chen CH; Li DJ; Li K
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1642-4. PubMed ID: 15569461
[TBL] [Abstract][Full Text] [Related]
12. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
[TBL] [Abstract][Full Text] [Related]
13. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
[TBL] [Abstract][Full Text] [Related]
14. C-Met antisense oligodeoxynucleotide inhibits growth of glioma cells.
Chu S; Yuan X; Li Z; Jiang P; Zhang J
Surg Neurol; 2006 Jun; 65(6):533-8; discussion 538. PubMed ID: 16720163
[TBL] [Abstract][Full Text] [Related]
15. MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.
Li J; Tian F; Li D; Chen J; Jiang P; Zheng S; Li X; Wang S
FEBS Lett; 2014 Sep; 588(18):3491-500. PubMed ID: 25131931
[TBL] [Abstract][Full Text] [Related]
16. [The effect of hepatitis B virus X gene transfection on expression of human telomerase reverse transcriptase mRNA in human bile duct carcinoma cell lines].
Qu ZL; Zou SQ; Wang X
Zhonghua Wai Ke Za Zhi; 2004 Oct; 42(20):1254-7. PubMed ID: 15598376
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF
Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclooxygenase-2 antisense vector on proliferation of human cholangiocarcinoma cells.
Wu GS; Zou SQ; Wu XY; Qiu FZ
Chin Med Sci J; 2004 Jun; 19(2):89-92. PubMed ID: 15250241
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients.
Huang XY; Ke AW; Shi GM; Ding ZB; Devbhandari RP; Gu FM; Li QL; Dai Z; Zhou J; Fan J
Cancer; 2010 Dec; 116(23):5440-51. PubMed ID: 20715158
[TBL] [Abstract][Full Text] [Related]
20. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
